Filing Flows

Filing Flows › Amkor Technology (AMKR) › Q3 2026 › vs Q3 2025

Amkor Technology (AMKR) Q3 2026 vs Q3 2025 (year over year)

Amkor Technology's revenue rose $3.6M (+0.2%) from $2.0B in Q3 2025 to $2.0B in Q3 2026. The biggest changes: Mainstream products +$55.5M (+18%); Advanced products −$51.9M (-3%). Gross margin 18.3% against 14.3% (+3.9 pts).

Amkor Technology, Q3 2026: revenue $2.0B (+0.2% year over year), operating margin 11.3%, net earnings $191M, operating cash flow $487M. The chart draws each line against Q3 2025, the increases inside each band.

Amkor Technology: what changed, Q3 2026 vs Q3 2025Amkor Technology: what changed, Q3 2026 vs Q3 2025Operating cash flow$318MCapital expenditures$302MWorking capital & other$231MGross profit$79.0MPre-tax earnings$75.8MCost of revenue−$75.5MOperating profit$65.8MNet earnings$64.2MMainstream products$55.5MAdvanced products−$51.9M

Margins

Q3 2026Q3 2025Change
Gross margin18.3%14.3%+3.9 pts
Operating margin11.3%8.0%+3.3 pts
Net margin9.6%6.4%+3.2 pts

Every line

LineQ3 2026Q3 2025Change%
Advanced products$1.6B$1.7B−$51.9M-3%
Mainstream products$359M$303M$55.5M+18%
Revenue$2.0B$2.0B$3.6M+0.2%
Gross profit$364M$284M$79.0M+28%
Cost of revenue$1.6B$1.7B−$75.5M-4%
Operating profit$225M$159M$65.8M+41%
Operating expenses$139M$126M$13.3M+11%
Pre-tax earnings$230M$154M$75.8M+49%
Research & development$39.8M$42.4M−$2.6M-6%
SG&A$99.0M$83.2M$15.8M+19%
Net earnings$191M$127M$64.2M+51%
Income tax$39.2M$27.7M$11.5M+42%
Depreciation$187M$164M$22.9M+14%
Working capital & other$109M−$122M$231M—
Operating cash flow$487M$169M$318M+189%
Capital expenditures$548M$246M$302M+123%
Negative free cash flow (OCF − capex)$61.6M$77.9M−$16.3M-21%

Questions

How much did Amkor Technology's revenue grow year over year in Q3 2026?

Amkor Technology's revenue rose $3.6M (+0.2%) from $2.0B in Q3 2025 to $2.0B in Q3 2026.

What drove Amkor Technology's revenue change in Q3 2026?

Mainstream products +$55.5M (+18%); Advanced products −$51.9M (-3%).

Q3 2026 results → · Compare in the interactive Sankey →